No new safety findings have been observed with continued blarcamesine treatment over three (3) years with good ... Investigator for the blarcamesine Phase IIb/III ANAVEX ® 2-73-AD-004 study.

1-3 The Phase 2 study is part of a seamless Phase 2 / Phase 3 program that includes three studies: a single Phase 2 study and two Phase 3 studies which have almost identical design. The Phase 2 ...

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ... including benefits in both progression-free and overall survival in frontline treatment, and we continue to observe strong ...